Email Us
Fully Integrated Data and Analytics Platform for COVID-19

Fully Integrated Data and Analytics Platform for COVID-19 CapitalBio

The employment of a single system to execute all functions that are capable of being accomplished by the combination of numerous systems is an example of fully integrated automation. This fully integrated data and analytics platform system has the potential to make operations much easier, make them less reliant on the expert experimental environment, and use fully integrated automation to avoid failures in experiments caused by human error. 

Types Of Fully Integrated Platform for COVID-19

CapitalBio SARS-CoV-2 Integrated Microfluidic Chip Analysis System
CapitalBio SARS-CoV-2 Integrated Microfluidic Chip Analysis System
The system, adopting two cutting-edge technologies, provides a “samples in, answers out”testing mode within 45 mins, including sample lysis, nucleic acid extraction, on-chip nested isothermal amplification, and fluorescence detection.
CapitalBio COVID-19 Mobile Laboratory
CapitalBio COVID-19 Mobile Laboratory
Combined with global leading chip laboratory technology and swab robot sampling technology, COVID-19 Mobile Laboratory can achieve “samples in, answers out”susceptible and rapid detection in various demand scenarios, such as border ports, CDC, grassroots hospitals, etc.
Cabin Laboratory
Cabin Laboratory
The laboratory is convenient to transport and has complete functions. After collecting samples, they can be tested on the spot, which reduces the time for sample circulation.

How Does A Fully Integrated Data And Analytics Platform?


CapitalBio Technology offers a fully integrated data and analytics platform designed to streamline data management and analysis processes.

  • The platform works by archiving all captured data, creating a comprehensive and organized database that can be easily accessed and retrieved when needed for business purposes.

  • This data archiving feature ensures that all valuable information is securely stored and readily available, enhancing the efficiency and effectiveness of data-driven decision making.

  • The platform also includes advanced analytics capabilities, allowing users to create detailed reports that provide valuable insights into various aspects of the business.

  • These analytics reports can be used to identify trends, patterns, and opportunities, supporting strategic planning and decision making.

  • In addition to analytics reporting, the platform also supports the building of Machine Learning models. These models can be used to refine predictions and improve the accuracy of forecasts.

  • By integrating data management, analytics, and Machine Learning capabilities into a single platform, CapitalBio Technology provides a comprehensive solution that can drive significant improvements in business performance.


Advantages of Using a Fully Integrated Data And Analytics Platform


  • Real-Time Data Processing and Analysis: The fully integrated data and analytics platform allows for the processing and analysis of data in real time. This enables CapitalBio Technology to make informed decisions promptly as new data becomes available, providing a competitive edge in the rapidly evolving biotechnology market.

  • Elimination of Data Silos: By integrating various data sources into a single platform, data silos are eliminated. This ensures a holistic view of all relevant information, enabling more accurate and insightful analyses.

  • Scalability: The cloud-based nature of the fully integrated data and analytics platform allows for seamless scaling as data volumes grow. This ensures efficient data management, regardless of the size of the data set.

  • Accessibility: Fully integrated data and analytics platforms provide access to data and analytics from anywhere, facilitating collaboration and increasing operational flexibility.

  • Improved Decision-Making: The comprehensive perspective provided by the fully integrated data and analytics platform leads to better decision-making and improved outcomes.

  • Competitive Advantage: The ability to process and analyze data efficiently and in real-time helps CapitalBio Technology maintain a competitive edge in the biotechnology industry.


Related CapitalBio Health Solutions

01
Solutions for Infectious Disease Control
CapitalBio provides comprehensive control solutions for infectious diseases, such as Respiratory Pathogens related diseases and Tuberculosis Bacteria related diseases, in order to assist clinicians in formulating precise diagnoses and treatment plans.
02
Solutions for Maternal and Child Healthcare
Based on the powerful testing platform and independent research and development capabilities, CapitalBio formed a congenital disability prevention and control program including NIPT, NIPT-PLUS, CNV-seq, and Deafness-related Gene Mutation detection, escort for the health of women and children.
03
Solutions for Anti-cancer Therapy
The new model of cancer diagnosis and treatment is genetic testing combined with targeted therapy, which will enhance both the effective rate and overall survival of cancer patients. CapitalBio anti-cancer solutions cover all stages of cancer development, from diagnosis to treatment to prognosis.
04
Solutions for Pharmacogenomics
Based on pharmacogenomics, Pharmacogenomics Testing makes prescription safer and more effective by detecting genes associated with drug metabolism, efficacy, and side effects. Given the stability of genes and the irreversibility of the impact of many ADRs, the test would benefit the entire life.
05
Solutions for Precise Healthcare Management
Combined with modern technology, traditional Chinese medicine diagnoses patients effectively and guides them to live healthy lives.
Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing